Dr. Kargi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
170 MANNING DRIVE
CB# 7060
Chapel Hill, NC 27599Phone+1 919-966-8804Fax+1 919-843-6520
Summary
- Dr. Atil Kargi is a clinical endocrinologist specializing in diseases of the pituitary gland including pituitary tumors, hypopituitarism, Cushing’s disease, Acromegaly, Prolactinoma, Adult Growth Hormone deficiency, and diabetes insipidus. He is the Co-Director of the UNC Pituitary Tumor Center and a Professor of Neurosurgery and Medicine.
Dr. Kargi’s focus is neuroendocrinology, which involves studying the interface between the brain and the various hormones that affect many aspects of a person’s health. Dr. Kargi enjoys the challenge and complexity that comes with treating patients with pituitary diseases. Dr. Kargi also enjoys working with the physicians that make up the multidisciplinary UNC Pituitary Tumor Center to develop the right treatment for each individual patient.
Dr. Kargi’s research interests focus on better understanding the biology of the pituitary gland and its hormones. He is also interested in improving diagnostic methods and medical therapies for patients with pituitary disorders. He looks forward to growing the department’s outcomes research and clinical trials programs. He plans to collaborate with other researchers at the UNC Medical Center to design and conduct research regarding the complex molecular biology that causes pituitary tumors to occur and grow. The ultimate goal of his molecular and genetic studies would be to develop new targets for pituitary tumor treatment.
Education & Training
- University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2008
- UPMC Medical EducationResidency, Internal Medicine, 2002 - 2005
- Dokuz Eylul University Faculty of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2009 - Present
- NC State Medical License 2022 - 2025
- FL State Medical License 2008 - 2024
- WA State Medical License 2005 - 2010
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Current State of Molecular Cytology in Thyroid Nodules: Platforms and Their Diagnostic and Theranostic Utility.Zeina C Hannoush, Roberto Ruiz-Cordero, Mark Jara, Atil Y Kargi
Journal of Clinical Medicine. 2024-03-19 - 1 citationsImpact of long-acting growth hormone replacement therapy in adult growth hormone deficiency: Comparison between adolescent, adult, and elderly patients.Atil Y Kargi
Best Practice & Research. Clinical Endocrinology & Metabolism. 2023-12-01 - 19 citationsMolecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.Simion Chiosea, Steven P Hodak, Linwah Yip, Devaprabu Abraham, Chelsey Baldwin
The Journal of Clinical Endocrinology and Metabolism. 2023-10-18
Authored Content
- Re: Ibuprofen Alters Human Testicular Physiology to Produce a State of Compensated HypogonadismApril 2018
Press Mentions
- Next Generation Medical Education Task Force to Design the Ideal Training for Doctors of the FutureFebruary 1st, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: